As of July 2026 Monopar Therapeutics has a market cap of NZ$1.23 Billion. This makes Monopar Therapeutics the world's 6865th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jul 29th, 2026 the market cap of Monopar Therapeutics was reported to be: